Received Oct 1, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| COVID19 | COVID19 (COVID19 (MODERNA MNEXSPIKE)) | MODERNA | UNK | 3052154 | IM |
headache; little bit of nausea; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (headache) and NAUSEA (little bit of nausea) in a 69-year-old male patient who received mRNA-1283 (MNEXSPIKE PFS) (batch no. 3052154) for COVID-19 prophylaxis. Previously administered products included for Product used for unknown indication: INFLUENZA VACCINE on 25-Aug-2025. Past adverse reactions to the above products included No adverse effect with INFLUENZA VACCINE. Concurrent medical conditions included Heart disorder (heart issues). Concomitant products included Ibuprofen (Advil) for an unknown indication. On 24-Sep-2025, the patient received dose of mRNA-1283 (MNEXSPIKE PFS) (Intramuscular use) .2 milliliter. On 25-Sep-2025, the patient experienced HEADACHE (headache) and NAUSEA (little bit of nausea). On 25-Sep-2025, HEADACHE (headache) and NAUSEA (little bit of nausea) had resolved. The patient had a headache and a little bit of nausea. These were dissipated within 24 hours. The patient did not experience any additional symptoms or events. It was unknown if the patient had any additional medical history, concomitant disease or risk factor. There was no lab data or results available. The treatment medication was not reported by the reporter.
Heart disorder (heart issues)
Advil